Canopus Biopharma Incorporated Stock Price on January 16, 2025
| CBIA Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Canopus Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Canopus BioPharma stands at 0.0001, as last reported on the 16th of January 2025, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. Canopus BioPharma is out of control given 3 months investment horizon. Canopus BioPharma secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 5.0% are justified by taking the suggested risk. Use Canopus BioPharma Mean Deviation of 25.41, risk adjusted performance of 0.149, and Downside Deviation of 53.03 to evaluate company specific risk that cannot be diversified away.
Canopus Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Canopus |
Sharpe Ratio = 0.1291
| Best Portfolio | Best Equity | CBIA | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 38.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.0 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Canopus BioPharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Canopus BioPharma by adding it to a well-diversified portfolio.
Canopus BioPharma Valuation on January 16, 2025
It is possible to determine the worth of Canopus BioPharma on a given historical date. On January 16, 2025 Canopus was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Canopus BioPharma pink sheet. Still, in general, we apply an absolute valuation method to find Canopus BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Canopus BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Canopus BioPharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,358,500 | |
01/16/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.00 |
| Backtest Canopus BioPharma | | | Canopus BioPharma History | | | Canopus BioPharma Valuation | Previous |
Canopus BioPharma Trading Date Momentum on January 16, 2025
| On January 16 2025 Canopus BioPharma Incorporated was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 0.0. Lack of trading volume on January 16, 2025 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Canopus BioPharma Fundamentals Correlations and Trends
By evaluating Canopus BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Canopus BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Canopus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Canopus BioPharma Pink Sheet history
Canopus BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Canopus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Canopus BioPharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Canopus BioPharma stock prices may prove useful in developing a viable investing in Canopus BioPharma
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. Canopus BioPharma Incorporated is based in Santa Monica, California. Canopus Biopharma is traded on OTC Exchange in the United States.
Canopus BioPharma Pink Sheet Technical Analysis
Canopus BioPharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Canopus BioPharma Period Price Range
Low | January 16, 2025
| High |
0.00 | 0.00 |
Canopus BioPharma Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Canopus BioPharma January 16, 2025 Market Strength
Market strength indicators help investors to evaluate how Canopus BioPharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Canopus BioPharma shares will generate the highest return on investment. By undertsting and applying Canopus BioPharma pink sheet market strength indicators, traders can identify Canopus BioPharma Incorporated entry and exit signals to maximize returns
Canopus BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Canopus BioPharma's price direction in advance. Along with the technical and fundamental analysis of Canopus Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Canopus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.149 | |||
| Jensen Alpha | 6.77 | |||
| Total Risk Alpha | 6.51 | |||
| Sortino Ratio | 0.1283 | |||
| Treynor Ratio | 1.01 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Canopus Pink Sheet analysis
When running Canopus BioPharma's price analysis, check to measure Canopus BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Canopus BioPharma is operating at the current time. Most of Canopus BioPharma's value examination focuses on studying past and present price action to predict the probability of Canopus BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Canopus BioPharma's price. Additionally, you may evaluate how the addition of Canopus BioPharma to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |